Article info
Aetiology/Harm
Cohort study
High-dose sulphonylurea treatment in patients with renal impairment should be considered with caution
- Correspondence to: Dr Eun Seok Kang, Department of Internal Medicine, Yonsei University College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, Seoul 03722, Korea; edgo{at}yuhs.ac
Citation
High-dose sulphonylurea treatment in patients with renal impairment should be considered with caution
Publication history
- First published January 27, 2017.
Online issue publication
March 23, 2017
Article Versions
- Previous version (27 January 2017).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/